oligonucleotide target TGF-beta (NeXstar)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameoligonucleotide target TGF-beta (NeXstar)
Drug Alias NameSELEX(NeXstar)TGF-beta antagonists (NeXstar)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsAngiogenesis disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorder

Other Information

ATC CodeN/A
Related LinksN/A